A T-cell-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma based on transcriptomics and single-cell sequencing

[1]  Qi Zhang,et al.  Single-cell atlases link macrophages and CD8+ T-cell subpopulations to disease progression and immunotherapy response in urothelial carcinoma , 2022, Theranostics.

[2]  Nan Wang,et al.  Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and therapeutic response in lung squamous cell carcinoma , 2022, Frontiers in Immunology.

[3]  Xu‐yong Wei,et al.  Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma , 2022, Computational and structural biotechnology journal.

[4]  Heming Lu,et al.  Tumor-Infiltrated CD8+ T Cell 10-Gene Signature Related to Clear Cell Renal Cell Carcinoma Prognosis , 2022, Frontiers in Immunology.

[5]  J. Ying,et al.  Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing , 2022, Frontiers in Immunology.

[6]  G. Lou,et al.  Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets , 2022, Frontiers in Genetics.

[7]  Di Huang,et al.  Turning cold tumors hot: from molecular mechanisms to clinical applications. , 2022, Trends in immunology.

[8]  B. Han,et al.  A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells , 2022, BMC Cancer.

[9]  Xianghui He,et al.  Single-Cell RNA Sequencing Revealed a 3-Gene Panel Predicted the Diagnosis and Prognosis of Thyroid Papillary Carcinoma and Associated With Tumor Immune Microenvironment , 2022, Frontiers in Oncology.

[10]  M. Ollert,et al.  Stress hormone signalling inhibits Th1 polarization in a CD4 T‐cell‐intrinsic manner via mTORC1 and the circadian gene PER1 , 2022, Immunology.

[11]  Chun‐Qing Song,et al.  Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma , 2021, Frontiers in Cell and Developmental Biology.

[12]  Hang Zheng,et al.  Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer , 2021, Cancer Cell International.

[13]  Wentao Jiang,et al.  A Five-Gene-Based Prognostic Signature for Hepatocellular Carcinoma , 2021, Frontiers in Medicine.

[14]  Qianqian Jiang,et al.  Identification and Validation of a Nine-Gene Amino Acid Metabolism-Related Risk Signature in HCC , 2021, Frontiers in Cell and Developmental Biology.

[15]  X. Zou,et al.  Prognostic and predictive role of a metabolic rate‐limiting enzyme signature in hepatocellular carcinoma , 2021, Cell proliferation.

[16]  J. Zeng,et al.  Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma , 2021, PeerJ.

[17]  Jian Wu,et al.  Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal Melanoma , 2021, Frontiers in Cell and Developmental Biology.

[18]  G. Lu,et al.  Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma , 2021, Bioscience reports.

[19]  Z. Zeng,et al.  What are the applications of single-cell RNA sequencing in cancer research: a systematic review , 2021, Journal of experimental & clinical cancer research : CR.

[20]  Yang Gu,et al.  A novel five‐gene signature predicts overall survival of patients with hepatocellular carcinoma , 2021, Cancer medicine.

[21]  P. Hogan,et al.  BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells , 2021, Nature Immunology.

[22]  M. Otuki,et al.  Hspa8 and ICAM‐1 as damage‐induced mediators of γδ T cell activation , 2021, Journal of leukocyte biology.

[23]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[24]  Huanming Yang,et al.  Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma , 2020, Cell.

[25]  Kang Xu,et al.  Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm. , 2020, International immunopharmacology.

[26]  Dihua Yu,et al.  Tumor microenvironment as a therapeutic target in cancer. , 2020, Pharmacology & therapeutics.

[27]  J. Ji,et al.  T-cell-based immunotherapy in colorectal cancer. , 2020, Cancer letters.

[28]  G. Ciliberto,et al.  T-cell agonists in cancer immunotherapy , 2020, Journal for ImmunoTherapy of Cancer.

[29]  Zemin Zhang,et al.  The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications , 2020, Cellular & Molecular Immunology.

[30]  J. Rathmell,et al.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy. , 2020, Molecular cell.

[31]  Hashem B. El-Serag,et al.  Epidemiology of Hepatocellular Carcinoma , 2020, Hepatology.

[32]  J. Barata,et al.  Flip the coin: IL-7 and IL-7R in health and disease , 2019, Nature Immunology.

[33]  Gao-Min Liu,et al.  Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma , 2019, Cancer Cell International.

[34]  J. Galon,et al.  Approaches to treat immune hot, altered and cold tumours with combination immunotherapies , 2019, Nature Reviews Drug Discovery.

[35]  M. Smyth,et al.  Cancer immunoediting and resistance to T cell-based immunotherapy , 2018, Nature Reviews Clinical Oncology.

[36]  Lai Guan Ng,et al.  Dimensionality reduction for visualizing single-cell data using UMAP , 2018, Nature Biotechnology.

[37]  A. Butte,et al.  Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage , 2018, Nature Immunology.

[38]  Qiong Zhang,et al.  GSCALite: a web server for gene set cancer analysis , 2018, Bioinform..

[39]  T. Schumacher,et al.  T Cell Dysfunction in Cancer. , 2018, Cancer cell.

[40]  N. Restifo,et al.  Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy. , 2017, Cell metabolism.

[41]  Pornpimol Charoentong,et al.  Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade , 2016, bioRxiv.

[42]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[43]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[44]  Ash A. Alizadeh,et al.  SUPPLEMENTARY NOTE , 1879, Botanical Gazette.

[45]  Ash A. Alizadeh,et al.  Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx. , 2020, Methods in molecular biology.

[46]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.